Global Study Director

Do you have expertise in Oncology, and experience with cell therapy? As a Global Study Director, Cell Therapy, Clinical Operations, you will deliver a single or several smaller Cell Therapy development programs.

Join us to apply your expertise to impact the lives of patients living with cancer, follow the science, and turn ideas into life-changing medicines. 

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. A place built on courage, curiosity and collaboration – we make bold decisions driven by patient outcomes. Empowered to lead at every level, free to ask questions and take smart risks that write the next chapter for our pipeline and Oncology team. 

Pioneers of collaborative research, we have built an unrivalled scientific community both internally and externally. Fusing academia and industry, we have united some of the world’s foremost medical centers. Working seamlessly and inclusively together, we expedite research in some of the hardest-to-treat cancers. Do you want an opportunity to build a rewarding and meaningful career as part of a team committed to improving the lives of millions with cancer? 

You will report to the Executive Director, Solid Tumor Cell Therapy Clinical Operations.

You Will:

• Clinical Operations delivery of a single or several smaller development programs or leading multiple studies or single sophisticated/novel studies. The exact accountabilities will differ depending on the exact nature of the clinical program so a high degree of flexibility and autonomy is required. 

• May also provide authoritative input to other non-drug programs and improvement projects. 

• Provides authoritative clinical operational input into project or study level documents, for example, clinical development plan, clinical study protocol, clinical study report, and may own the delivery of study documents 

• May lead and deliver differentiated and robust operational options for review at Investment Decision Governance interactions 

• Owns the delivery of the clinical study(s) or program(s) from concept to final CSR and through to study closed and archived to agreed budget, time, project standards, quality and scientific standards 

• Accountable for overall study or program deliverables, maintaining oversight throughout the life of the study or program by close interaction with individual study/program leaders or leadership of the study team as appropriate 

• Ensure sponsor oversight throughout the life of the study 

• Develops and leads effective risk management/mitigation plans to ensure timely delivery to quality, budget and time and advance issues to partners as appropriate 

• Responsible for planning and leading issue customer concern and resolution 

• Provide input to forecasting and management of study/program delivery costs, resource and timelines 

• Accountable for the quality of study/program planning information into relevant planning systems 

• Mentors and supports the development of individuals within the organization 

• Contributes to operational interactions with external entities, including regulatory agencies, preferred partners/suppliers, and external collaborators 

• Responsible for oversight of CROs and other clinically outsourced third-party vendors for outsourced studies and programs 

• <